Docoh
Loading...

COCP Cocrystal Pharma

News

Pro users get this 30m faster
12 Health Care Stocks Moving In Friday's After-Market Session
3 Sep 21
Movers
Gainers
Cocrystal Pharma Q2 EPS $(0.04) Up From $(0.07) YoY
16 Aug 21
Earnings, News
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.
12 Health Care Stocks Moving In Friday's Pre-Market Session
30 Jul 21
Pre-Market Outlook, Markets, Movers
20 Stocks Moving in Friday's Pre-Market Session
30 Jul 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation.
12 Health Care Stocks Moving In Thursday's Intraday Session
29 Jul 21
Movers
Gainers
Cocrystal Pharma Stock Is Trading Higher After COVID-19 Candidate Shows Preclinical Activity Against Delta, Gamma Variants
29 Jul 21
Biotech, Long Ideas, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Thursday's Pre-Market Session
29 Jul 21
Pre-Market Outlook, Markets, Movers
Cocrystal Pharma Announces Its SARS-CoV-2 3CL Protease Lead CDI-45205 Showed In Vitro Activity Against Delta And Gamma Variants
29 Jul 21
Biotech, News, FDA, General
Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") announces that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity

Press releases

Pro users get this 30m faster
Cocrystal Pharma to Present at the Dawson James 2021 Small Cap Growth Conference on October 21, 2021
14 Oct 21
Press Releases
BOTHELL, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that
Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza
6 Oct 21
Press Releases
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that
New COVID-19 Vaccination Mandates Make Rapid COVID Tests More Essential Than Ever
19 Aug 21
Opinion, Press Releases
NEW YORK, Aug. 19, 2021 /PRNewswire/ -- With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated, the need for rapid testing and
California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers
3 Aug 21
Small Cap, Opinion, Press Releases
NEW YORK, Aug. 3, 2021 /PRNewswire/ -- New COVID-19 cases continue to surge throughout the United States, causing municipal governments to spring into action to combat the rising number of the highly infectious Delta
Thinking about buying stock in Taoping, Xenetic Biosciences, Cocrystal Pharma, Nikola Corp, or SCWorx?
30 Jul 21
Opinion, Press Releases
NEW YORK, July 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TAOP, XBIO, COCP, NKLA, and WORX.
Thinking about buying stock in Sundial Growers, Cocrystal Pharma, Vaxart, Titan Medical, or Seanergy Maritime?
29 Jul 21
Opinion, Press Releases
NEW YORK, July 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, COCP, VXRT, TMDI, and SHIP.